Biologics Platform
Biologics Access
All members receive access to biologics and product documentation, pricing, online training resources, clinic launch templates and certification pathway.
- Exosome-related products
- Umbilical cord blood-derived biologics
- Wharton’s Jelly-derived biologic materials
- Research-use material
- Peptides
- Nutraceuticals
Professional Support
Designed for clinics and physicians who want to distinguish themselves from ordinary stem cell and biologics clinics.
Monthly education seminar for licensed physicians and qualified medical professionals entering or expanding biologics services, plus access to our WhatsApp channel.
- Regenerative medicine fundamentals
- Exosome science
- Perinatal tissue biology
- Safety monitoring
- Protocol Orientation
- Patient Selection Framework
- Documentation standards
Regulatory Discipline & Responsible Use Statement
GIOSTAR Biologics is committed to responsible regenerative medicine. Regenerative biologics may be subject to significant regulatory restrictions. Certain biologic products may require FDA approval, an IND, or other regulatory authorization before clinical use in the United States. Product access, clinical use, marketing, and distribution depend on applicable law, provider qualifications, product category, jurisdiction, and intended use.
GIOSTAR Biologics does not encourage unsupported disease-treatment claims or irresponsible marketing. All providers are expected to comply with applicable federal, state, and local law, medical board requirements, informed consent obligations, and product-use restrictions.